Remus Pharmaceuticals Limited
ListedSMEPharmaceuticals & Healthcare · NSE
Incorporated in 2015, Remus Pharmaceuticals Limited is engaged in the marketing and distribution of pharmaceutical products, including Active Pharmaceutical Ingredients (APIs) and finished formulations in various dosage forms. As of January 31, 2023, the company offers 429 products, with 295 registered in 13 countries and 134 under registration in 16 countries. Remus Pharmaceuticals maintains business-to-business agreements with 58 domestic and 139 international distributors, serving clients across more than 20 countries, including generic distributors, regional distributors, multinational distributors, hospitals, and clinics.
Price Band
₹1150 – ₹1229
Issue Size
₹47.69 Cr
Lot Size
100 shares
GMP
₹470
+38.2%
Est. Listing
₹1699
at current GMP
Subscribed
61.53x
overall
Open
17 May 2023
Close
19 May 2023
Allotment
24 May 2023
Refund
25 May 2023
Demat Credit
26 May 2023
Listing
29 May 2023
Last updated 12 days ago
Official Registrar Verification
Remus Pharmaceuticals Limited Allotment Status
Designated Registrar: Link Intime India Private Limited
Allotment Date
24 May 2023
Basis finalization
Refunds Initiate
25 May 2023
Mandate release
Demat Credit
26 May 2023
Shares in demat
Listing Debut
29 May 2023
Trading begins
How to Check Remus Pharmaceuticals Limited IPO Allotment Status
- Click the Check on Registrar button above to visit Link Intime India Private Limited's allotment portal.
- Select Remus Pharmaceuticals Limited from the dropdown company list.
- Choose your lookup mode: PAN Number, Application Number, or DP Client ID.
- Enter your details accurately and solve the Captcha code.
- Click Submit / Search to view the number of shares applied and allotted to you.
About Remus Pharmaceuticals Limited Public Issue & Market Profile
Remus Pharmaceuticals Limited is bringing an initial public offering (IPO) in the Pharmaceuticals & Healthcare sector with an aggregate issue size of ₹47.69 Crores. The shares are offered at a price band of ₹1150 to ₹1229 per equity share on NSE. Currently, traders and retail applicants are calculating expected listing gains and break-even points based on unofficial grey market quotations.
Public Issue & Allotment Procedure:
Prospective investors can apply in the retail quota with a minimum of 1 lot comprising 100 shares (approx. ₹1,22,900 minimum investment). High net-worth individuals (HNI/NII) can bid in the sHNI (₹2 Lakh to ₹10 Lakh) or bHNI (above ₹10 Lakh) categories for enhanced quota allocation.
Official Allotment Timelines & Registrar Guidance:
Allotment reconciliation will be managed by Link Intime India Private Limited. Eligible allottees will receive credit of equity shares into their Demat accounts by 2023-05-26, while un-allotted funds or UPI block mandates will be released on 2023-05-25.
Frequently Asked Questions
What if my name is not showing on the registrar portal?
Allotment records are updated in batches. If the status is not yet available, please wait a few hours until the basis of allotment is fully finalized.
How will I receive the refund if I don't get allotment?
Since funds are blocked under ASBA/UPI, the bank will automatically release the blocked hold on your funds upon receipt of revocation instructions from the sponsor bank.